We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Rapt Therapeutics Inc
8 own
5 watching
Current Price
$0
$0.15
(0.71%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
721.8M
52-Week High
32.45
52-Week Low
13.31
Average Volume
0.08M
Dividend Yield
--
P/E Ratio
--
Market Capitalization721.8M52-Week High32.4552-Week Low13.31Average Volume0.08MDividend Yield--P/E Ratio--What does the Rapt Therapeutics Inc do?
RAPT Therapeutics, Inc.is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Read More
How much money does Rapt Therapeutics Inc make?
News & Events about Rapt Therapeutics Inc.
Ticker Report
1month ago
RAPT Therapeutics, Inc. (NASDAQ:RAPT Get Rating) insider William Ho sold 5,000 shares of the stock in a transaction dated Wednesday, April 19th. The shares were sold at an average price of $18.88, for a total value of $94,400.00. Following the transaction, the insider now directly owns 20,...
PR Newswire
2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT PR Newswire NEW YORK, April 3, 2023 NEW YORK, April 3, 2023...
PR Newswire
2 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RAPT Therapeutics, Inc. - RAPT PR Newswire NEW YORK, March 22, 2023 NEW YORK, March 22, 2023...
Globe Newswire
2 months ago
ATLANTA, March 20, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether RAPT Therapeutics, Inc. (RAPT Therapeutics,or the Company) (NASDAQ: RAPT) complied with federal securities laws. On March 14, 2023, the Company disclosed that for its Phase 2b trial of RPT193 in atopic ...
Globe Newswire
2 months ago
Company maintains strong cash position of $249.1 millionSOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies...
Frequently Asked Questions
Frequently Asked Questions
What is Rapt Therapeutics Inc share price today?
Can Indians buy Rapt Therapeutics Inc shares?
How can I buy Rapt Therapeutics Inc shares from India?
Can Fractional shares of Rapt Therapeutics Inc be purchased?
What are the documents required to start investing in Rapt Therapeutics Inc stocks?
What is today’s traded volume of Rapt Therapeutics Inc?
What is today’s market capitalisation of Rapt Therapeutics Inc?
What is the 52-Week High and Low Range of Rapt Therapeutics Inc?
What percentage is Rapt Therapeutics Inc down from its 52-Week High?
What percentage is Rapt Therapeutics Inc up from its 52-Week Low?
Current Price
$0
$0.15
(0.71%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.